Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neutral sphingomyelinase 2 (nSMase2) is a membrane-bound enzyme that catalyzes the hydrolysis of sphingomyelin to generate ceramide and phosphocholine. Ceramide, a bioactive lipid, is involved in various cellular processes including inflammatory signaling, exosome generation, cell growth regulation, and apoptosis. nSMase2 is implicated in diseases such as cancer, neurodegeneration, and inflammatory disorders, making it a potential therapeutic target.
Lipid competitive inhibitor (e.g., GW4869)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutral Sphingomyelinase 2 (nSMase2).